Spots Global Cancer Trial Database for EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy
Official Title: Evaluation of the EPIONE Robotic System for Image-guided Percutaneous Bone Procedures A Prospective Study on Feasibility, Safety and Accuracy
Study ID: NCT06376682
Interventions
Study Description
Brief Summary: Interventional clinical study to obtain performance and safety data of the EPIONE® device when used for bone percutaneous procedures.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Thierry DE BAERE
Affiliation: Gustave Roussy Cancer Institute
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
